BASTIDE: Bastide Group strengthens in strategic areas with new acquisitions in France – 01/05/2022 at 7:30 p.m.


Caissargues, January 5, 2022 – 5:45 p.m. CET – Bastide Le Confort Médical (Euronext Paris Compartiment B: BLC, FR0000035370), specialist in home healthcare, announces that it has made acquisitions in several strategic areas in France. With greater financial leeway following its recent refinancing operation, the Group has resumed an active external growth policy in order to increase the digital part of its activity and its volume of business in its higher-value businesses. added.

Acquisition of a leader in the online distribution of medical devices and a start-up specializing in bringing together healthcare professionals

Groupe Bastide has acquired the company Distrimed, French number 2 in the online sale of medical devices intended for healthcare professionals. This digital player achieved a turnover of 12.3 million euros in 2020 and delivers profitability above Group standards. Distrimed will be consolidated in the accounts of the Bastide Group from 1

er

December 2021. At the same time, Groupe Bastide also acquired the company Care Service, which offers innovative digital solutions for bringing together healthcare professionals. Care Service, which does not yet generate any turnover, will also be included in the accounts on the date of 1

er

December 2021. Through these two operations, the Bastide Group reaffirms its ambition to become a major player in the online sale of medical devices in order to strengthen its profitability, in a healthcare market where the trend towards digital is still a trend. stronger and lasting, further accentuated by the current health context.

Acquisition of a regional player to strengthen the territorial network in the field of infusion

Bastide finalized on January 4 the acquisition of the entire capital of Saad Perfusion, a player specializing in perfusion in the Grand-Est region, where it generated € 0.7 million in sales in 2020 with a margin greater than that of the Group. Included in the Groupe Bastide accounts on the date of 1

er

January 2022, Saad Perfusion will strengthen Bastide’s territorial network on its domestic market in a promising and profitable business.

The completion of these acquisitions, aimed at rapidly increasing profitability, strengthens the Group’s strategic vision according to which digital is the foundation for the transformation of the supply of medical devices and services, as well as the strengthening of the territorial network in the businesses. with high added value.

About Groupe Bastide Le Confort Médical

Created in 1977 by Guy Bastide, the BASTIDE Group is one of the main European players in the provision of home health care. Present in 5 countries, BASTIDE is developing a permanent quality approach and is committed to providing the medical devices and associated services that best meet the needs of patients in key health areas: diabetes, nutrition, infusion, respiratory, stomatherapy and urology. . BASTIDE is listed on Euronext Paris (ISIN: FR0000035370, Reuters BATD.PA, – Bloomberg BLC: FP).

Bastide Group

NewCap

NewCap


Vincent Bastide

Olivier Jourdanney

T. +33 (0) 4 66 38 68 08

Investor relations


Emmanuel Huynh

T. +33 (0) 1 44 71 20 42

[email protected]


Press relations


Nicolas merigeau

T. +33 (0) 1 44 71 94 98

[email protected]


This publication has the service “? Actusnews SECURITY MASTER”.


– SECURITY MASTER Key:

xmmbZ8prlGvKnJ5slcdrl2lqmW6SyGiYZWfJyWFvZZbGampoxptoaJ3JZnBjm2Zm

– To check this key:

https://www.security-master-key.com.



Regulated information:


Inside information:

– Issuer operations (acquisitions, disposals, etc.)


Full and original press release in PDF format:

https://www.actusnews.com/news/72610-05-01-22-cp_bastide-acquisitions-fr.pdf

© Copyright Actusnews Wire

Receive free company updates by email by subscribing to www.actusnews.com



Source link -86